Masaharu Inoue

2.7k total citations
114 papers, 2.1k citations indexed

About

Masaharu Inoue is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Masaharu Inoue has authored 114 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 29 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Masaharu Inoue's work include Bladder and Urothelial Cancer Treatments (19 papers), Urinary and Genital Oncology Studies (13 papers) and Renal cell carcinoma treatment (10 papers). Masaharu Inoue is often cited by papers focused on Bladder and Urothelial Cancer Treatments (19 papers), Urinary and Genital Oncology Studies (13 papers) and Renal cell carcinoma treatment (10 papers). Masaharu Inoue collaborates with scholars based in Japan, Hungary and Canada. Masaharu Inoue's co-authors include Yutaka Toyozawa, Toshimasa Onaya, Masato Tawata, Eva Klein, Teturô Inui, Makoto Okazaki, Eiichi Hanamura, Norihiko Yokomori, T. ESKELAND and Bo Johansson and has published in prestigious journals such as Physical Review Letters, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Masaharu Inoue

108 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaharu Inoue Japan 24 603 519 319 284 262 114 2.1k
Hirokazu Sasaki Japan 30 340 0.6× 433 0.8× 131 0.4× 185 0.7× 570 2.2× 158 2.5k
Shinichi Itoh Japan 30 607 1.0× 407 0.8× 220 0.7× 410 1.4× 240 0.9× 209 3.2k
Hirohiko M. Shimizu Japan 27 710 1.2× 393 0.8× 107 0.3× 466 1.6× 123 0.5× 246 2.7k
Mélanie Gauthier France 27 204 0.3× 312 0.6× 191 0.6× 194 0.7× 192 0.7× 69 1.9k
Kentaro Ueda Japan 30 536 0.9× 480 0.9× 288 0.9× 464 1.6× 315 1.2× 124 2.6k
Kenichi Yoshida Japan 28 286 0.5× 342 0.7× 322 1.0× 714 2.5× 307 1.2× 142 2.4k
Kozo Hoshino Japan 31 702 1.2× 1.6k 3.1× 150 0.5× 368 1.3× 331 1.3× 189 3.5k
Hans Wägner Germany 28 666 1.1× 662 1.3× 170 0.5× 267 0.9× 233 0.9× 170 3.6k
Hiroshi Yasuhara Japan 24 744 1.2× 164 0.3× 371 1.2× 129 0.5× 765 2.9× 157 2.3k
Magnus Nord Sweden 31 166 0.3× 500 1.0× 793 2.5× 619 2.2× 291 1.1× 93 2.6k

Countries citing papers authored by Masaharu Inoue

Since Specialization
Citations

This map shows the geographic impact of Masaharu Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaharu Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaharu Inoue more than expected).

Fields of papers citing papers by Masaharu Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaharu Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaharu Inoue. The network helps show where Masaharu Inoue may publish in the future.

Co-authorship network of co-authors of Masaharu Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Masaharu Inoue. A scholar is included among the top collaborators of Masaharu Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaharu Inoue. Masaharu Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Takanobu, Sho Uehara, Masaharu Inoue, et al.. (2024). Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study. International Journal of Clinical Oncology. 29(9). 1302–1310. 2 indexed citations
2.
Ando, Kiyohiro, Noriko Motoi, Toshihiko Iizuka, et al.. (2024). STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer. Anticancer Research. 44(5). 1925–1930. 1 indexed citations
3.
4.
Inoue, Masaharu, Satoshi Washino, Suguru Shirotake, et al.. (2022). Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non‐clear cell renal cell carcinoma: Real‐world data from a Japanese multicenter retrospective study. International Journal of Urology. 30(9). 714–721. 9 indexed citations
5.
Ando, Kiyohiro, Masaharu Inoue, Hisanori Takenobu, et al.. (2022). Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Research. 42(2). 1131–1136. 15 indexed citations
6.
7.
Kawamura, Naoko, Kazutaka Saito, Masaharu Inoue, et al.. (2018). Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy. Urologia Internationalis. 101(4). 437–442. 26 indexed citations
8.
Nakamura, Yuki, Soichiro Yoshida, Hiroshi Tanaka, et al.. (2017). Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urologia Internationalis. 98(3). 298–303. 7 indexed citations
9.
Inoue, Masaharu, Fumitaka Koga, Soichiro Yoshida, et al.. (2014). Significance of ERBB2 Overexpression in Therapeutic Resistance and Cancer-Specific Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Selective Bladder-Sparing Approach. International Journal of Radiation Oncology*Biology*Physics. 90(2). 303–311. 32 indexed citations
10.
Mori, Takeshi, et al.. (2000). Bactericidal Effects of Disinfectants on Clinical Isolates from the Hospital. (Report 4).. Japanese Journal of Hospital Pharmacy. 26(6). 652–658. 4 indexed citations
11.
Miura, Yukio, et al.. (2000). Primary aldosteronism as a cause of severe postpartum hypertension in two women. American Journal of Obstetrics and Gynecology. 182(3). 745–746. 18 indexed citations
12.
Inoue, Masaharu, et al.. (1992). A synthetic analogue of vitamin D3, 22-oxa-1,25-dihydroxy-vitamin D3, stimulates the production of prostacyclin by vascular tissues. Life Sciences. 51(14). 1105–1112. 9 indexed citations
13.
Shimokawa, Hiroaki, Masaharu Inoue, K. Hara, Hideki Nakano, & Hajime Maeda. (1987). Intrauterine Treatment of Nonimmunologic Hydrops Fetalis. 日本産科婦人科學會雜誌. 39(8). 1380–1381. 1 indexed citations
14.
Ikeda, Haruo, Masaharu Inoue, & Satoshi Ōmura. (1983). Improvement of macrolide antibiotic-producing streptomycete strains by the regeneration of protoplasts.. The Journal of Antibiotics. 36(3). 283–288. 19 indexed citations
15.
Ōmura, Satoshi, Yoshitake Tanaka, Akira Nakagawa, et al.. (1982). Irumamycin, a new antibiotic active against phytopathogenic fungi.. The Journal of Antibiotics. 35(2). 256–257. 27 indexed citations
16.
17.
Yokohama, Michinari, et al.. (1979). The Isolation of Pure Horse Transferrin Protein by DEAE Sephadex Chromatogram and Gel Filtration and the Production of the Corresponding Specific Antibody. Nihon Chikusan Gakkaiho. 50(10). 705–709. 1 indexed citations
18.
Killander, D., Alan S. Levin, Masaharu Inoue, & Eva Klein. (1970). Quantification of immunofluorescence on individual erythrocytes coated with varying amounts of antigen.. PubMed. 19(1). 151–6. 22 indexed citations
19.
Klein, Eva, T. ESKELAND, Masaharu Inoue, Roberto Ström, & Bo Johansson. (1970). Surface immunoglobulin-moieties on lymphoid cells. Experimental Cell Research. 62(1). 133–148. 67 indexed citations
20.
Okazaki, Makoto, et al.. (1966). Local and Band Structures in the Fundamental Absorption Spectra of One-Dimensional Crystals. Journal of the Physical Society of Japan. 21(1). 209–210. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirokazu Sasaki Breakdown of academic impact, for papers by Shinichi Itoh Breakdown of academic impact, for papers by Hirohiko M. Shimizu Breakdown of academic impact, for papers by Mélanie Gauthier Breakdown of academic impact, for papers by Kentaro Ueda Breakdown of academic impact, for papers by Kenichi Yoshida Breakdown of academic impact, for papers by Kozo Hoshino Breakdown of academic impact, for papers by Hans Wägner Breakdown of academic impact, for papers by Hiroshi Yasuhara Breakdown of academic impact, for papers by Magnus Nord
Rankless by CCL
2026